These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 36318966)

  • 21. [Current aspects of antirheumatic therapy in pregnancy planning, during pregnancy and breastfeeding].
    Häfeli C; Förger F
    Z Rheumatol; 2021 Oct; 80(8):716-725. PubMed ID: 34581874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lactation and Management of Postpartum Disease.
    Bermas BL
    Rheum Dis Clin North Am; 2017 May; 43(2):249-262. PubMed ID: 28390567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comment on: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding.
    Schreiber K; Frishman M; Hunt BJ
    Rheumatology (Oxford); 2023 May; 62(5):e164-e165. PubMed ID: 36545701
    [No Abstract]   [Full Text] [Related]  

  • 24. BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs.
    Ledingham J; Gullick N; Irving K; Gorodkin R; Aris M; Burke J; Gordon P; Christidis D; Galloway S; Hayes E; Jeffries A; Mercer S; Mooney J; van Leuven S; Galloway J;
    Rheumatology (Oxford); 2017 Jun; 56(6):865-868. PubMed ID: 28339817
    [No Abstract]   [Full Text] [Related]  

  • 25. Therapy: A fine conception -- BSR/BHPR guidelines on drugs in pregnancy.
    Sammaritano LR; Bermas BL
    Nat Rev Rheumatol; 2016 Apr; 12(4):197-8. PubMed ID: 26984054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rheumatic immune-related adverse events secondary to anti-programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case series.
    Mitchell EL; Lau PKH; Khoo C; Liew D; Leung J; Liu B; Rischin A; Frauman AG; Kee D; Smith K; Brady B; Rischin D; Gibson A; Mileshkin L; Klein O; Weickhardt A; Arulananda S; Shackleton M; McArthur G; Östör A; Cebon J; Solomon B; Buchanan RR; Wicks IP; Lo S; Hicks RJ; Sandhu S
    Eur J Cancer; 2018 Dec; 105():88-102. PubMed ID: 30439628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Institute of Rheumatology and progress of antirheumatic therapy].
    Sigidin IaA
    Vestn Ross Akad Med Nauk; 1998; (12):7-9. PubMed ID: 9987950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How safe are anti-rheumatic drugs during pregnancy?
    Østensen M; Förger F
    Curr Opin Pharmacol; 2013 Jun; 13(3):470-5. PubMed ID: 23522967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reflections on 'older' drugs: learning new lessons in rheumatology.
    Kerrigan SA; McInnes IB
    Nat Rev Rheumatol; 2020 Mar; 16(3):179-183. PubMed ID: 32066941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Breastfeeding and drug management in connective tissue and rheumatic diseases].
    Weber JC; Kuhnert C
    Rev Med Interne; 2008 Dec; 29(12):1017-23. PubMed ID: 18799245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical characteristics of COVID-19 patients with underlying rheumatic diseases in Japan: data from a multicenter observational study using the COVID-19 Global Rheumatology Alliance physician-reported registry.
    Kihara M; Sugihara T; Asano J; Sato M; Kaneko H; Muraoka S; Ohshima S; Nanki T
    Clin Rheumatol; 2022 Dec; 41(12):3661-3673. PubMed ID: 35974224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New horizons in the use of biological agents during pregnancy in patients with rheumatic disease].
    Shesternya PA; Petrova MM; Vasilyeva AO
    Ter Arkh; 2017; 89(5):105-112. PubMed ID: 28631708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rheumatologic Medication Use During Pregnancy.
    Peterson EA; Lynton J; Bernard A; Santillan MK; Bettendorf B
    Obstet Gynecol; 2020 May; 135(5):1161-1176. PubMed ID: 32282595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reproductive Rheumatology: Meeting Today's Challenges.
    Sammaritano LR; Chakravarty EF
    Rheum Dis Clin North Am; 2017 May; 43(2):xiii-xiv. PubMed ID: 28390572
    [No Abstract]   [Full Text] [Related]  

  • 35. Prescribing of sulfasalazine, azathioprine and methotrexate round pregnancy--a descriptive study.
    Vroom F; van Roon EN; van den Berg PB; Brouwers JR; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):52-61. PubMed ID: 17948319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimisation of antirheumatic drug treatment in pregnancy.
    Ostesen M
    Clin Pharmacokinet; 1994 Dec; 27(6):486-503. PubMed ID: 7882637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Rational utilization of corticosteroids in rheumatology].
    Demers R
    Union Med Can; 1967 Aug; 96(8):933-5. PubMed ID: 5306679
    [No Abstract]   [Full Text] [Related]  

  • 38. Rheumatic diseases and pregnancy: a national survey about practice patterns among rheumatologists and obstetricians.
    Fayad F; Ziade N; Karam GA; Ghaname W; Khamashta M
    Clin Exp Rheumatol; 2018; 36(6):1014-1021. PubMed ID: 29846160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020.
    Richez C; Flipo RM; Berenbaum F; Cantagrel A; Claudepierre P; Debiais F; Dieudé P; Goupille P; Roux C; Schaeverbeke T; Wendling D; Pham T; Thomas T
    Joint Bone Spine; 2020 Oct; 87(5):431-437. PubMed ID: 32473418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Which anti-inflammatory agents should be used in rheumatology?].
    Gerster JC
    Schweiz Med Wochenschr; 1981 Feb; 111(8):266-71. PubMed ID: 7015496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.